• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Coagulation Disorder (1779)
Event Date 11/01/2022
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
But it failed in treating the bleeding for the patient's postpartum primary hemorrhage [device ineffective].The patient was coagulopathic [coagulopathy].Case narrative: this spontaneous report was received from a physician via company representative referring to a female patient of unknown age.The patient's historical conditions included pregnancy (also reported as "pregnant: yes"; discrepant information) and vaginal delivery.Her concurrent conditions, concomitant medications, and allergies were not reported.This report concerns 1 patient and 1 device.Approximately on an unknown date in (b)(6) 2022 (reported as "sometime last week"), the patient was started on vacuum-induced hemorrhage control system (jada system) via vaginal route for post-partum primary hemorrhage (postpartum haemorrhage (primary)) (lot# and expiration date were not reported).The reporter stated that it sounded like everything went right with the actual device, but it failed in treating the bleeding for the patient's postpartum primary hemorrhage (device ineffective, onset date: unknown date in (b)(6) 2022).The patient was coagulopathic (coagulopathy), but it was unknown if this was discovered prior to vacuum-induced hemorrhage control system (jada system) use or after.It was also reported that for some reason the staff using it were concerned that blood went into the cannister and weren't sure if something was wrong with the device, but the healthcare professional (hcp) told them that it was normal.The patient ended up getting a hysterectomy (also reported as treatment), but other details of the patient's outcome were unknown.It was also reported that the patient sought medical attention and the patient did not die.No other adverse event (ae) and product quality complaint (pqc) were reported.No additional information was provided.The availability of vacuum-induced hemorrhage control system (jada system) was unknown.The action taken with vacuum-induced hemorrhage control system (jada system) with respect to the event of coagulopathy was reported as withdrawn approximately on an unknown date in (b)(6) 2022.The outcome of coagulopathy was unknown.The causality assessment between the event of coagulopathy and vacuum-induced hemorrhage control system (jada system) was not provided.Upon internal review, the event of "device ineffective" was determined to be serious as it required intervention.Medical device reporting criteria: serious injury.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key15879913
MDR Text Key304463640
Report Number3002806821-2022-00015
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-